Anti-Vascular endothelial growth factor therapy impairs endothelial function of retinal microcirculation in colon cancer patients – an observational study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Experimental & Translational Stroke Medicine 2013, 5:7, ISSN: 2040-7378
- Event
-
Veröffentlichung
- (where)
-
Dresden
- (who)
-
Technische Universität Dresden
- (when)
-
2014
- Event
-
Veröffentlichung
- (where)
-
Dresden
- (who)
-
Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden
- (when)
-
2014
- Creator
-
Reimann, Manja
Folprecht, Gunnar
Haase, Rocco
Trautmann, Karolin
Ehninger, Gerhard
Reichmann, Heinz
Ziemssen, Focke
Ziemssen, Tjalf
- URN
-
urn:nbn:de:bsz:14-qucosa-127167
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Reimann, Manja
- Folprecht, Gunnar
- Haase, Rocco
- Trautmann, Karolin
- Ehninger, Gerhard
- Reichmann, Heinz
- Ziemssen, Focke
- Ziemssen, Tjalf
- Technische Universität Dresden
- Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden
Time of origin
- 2014
Other Objects (12)
Anti-Vascular endothelial growth factor therapy impairs endothelial function of retinal microcirculation in colon cancer patients – an observational study
The Management of Two Cases with Retinal Arterial Macroaneurysm by Anti-Vascular Endothelial Growth Factor
Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
Anti-Vascular Endothelial Growth Factor Treatment Compared with Steroid Treatment for Retinal Vein Occlusion: A Meta-Analysis
Time to initiate anti-vascular endothelial growth factor therapy and visual outcome in central retinal vein occlusion
Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy
Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion
Endothelial Cdc42 deficiency impairs endothelial regeneration and vascular repair after inflammatory vascular injury
Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase
Risk of retinal vein occlusion in colorectal cancer patients receiving anti-vascular endothelial growth factors – a population-based cohort study
Aging impairs the ability of vascular endothelial stem cells to generate endothelial cells in mice
Anti-Vascular endothelial growth factor therapy impairs endothelial function of retinal microcirculation in colon cancer patients – an observational study
The Management of Two Cases with Retinal Arterial Macroaneurysm by Anti-Vascular Endothelial Growth Factor
Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
Anti-Vascular Endothelial Growth Factor Treatment Compared with Steroid Treatment for Retinal Vein Occlusion: A Meta-Analysis
Time to initiate anti-vascular endothelial growth factor therapy and visual outcome in central retinal vein occlusion
Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy
Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion
Endothelial Cdc42 deficiency impairs endothelial regeneration and vascular repair after inflammatory vascular injury
Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase
Risk of retinal vein occlusion in colorectal cancer patients receiving anti-vascular endothelial growth factors – a population-based cohort study
Aging impairs the ability of vascular endothelial stem cells to generate endothelial cells in mice
Anti-Vascular endothelial growth factor therapy impairs endothelial function of retinal microcirculation in colon cancer patients – an observational study
The Management of Two Cases with Retinal Arterial Macroaneurysm by Anti-Vascular Endothelial Growth Factor
Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
Anti-Vascular Endothelial Growth Factor Treatment Compared with Steroid Treatment for Retinal Vein Occlusion: A Meta-Analysis
Time to initiate anti-vascular endothelial growth factor therapy and visual outcome in central retinal vein occlusion
Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy
Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion
Endothelial Cdc42 deficiency impairs endothelial regeneration and vascular repair after inflammatory vascular injury
Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase
Risk of retinal vein occlusion in colorectal cancer patients receiving anti-vascular endothelial growth factors – a population-based cohort study